Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

Area of Science:

• Immunology
• Infectious Diseases
• Critical Care Medicine

Background:

• Sepsis is a severe, life-threatening infection characterized by organ dysfunction.
• It involves a complex interplay of pro-inflammatory and anti-inflammatory host responses.
• The balance between these immune pathways is crucial for patient survival.

Purpose of the Study:

• To explore the pathophysiological basis of sepsis.
• To understand the mechanisms of pro- and anti-inflammatory responses in sepsis.
• To propose novel therapeutic strategies for sepsis treatment.

Main Methods:

• Review of existing sepsis research.
• Analysis of host immune responses during sepsis.
• Conceptualization of biomarker-guided immunotherapy.

Main Results:

• Sepsis outcome is determined by the balance between competing inflammatory pathways.
• Understanding these mechanisms is key to developing new treatments.
• Biomarker-guided immunotherapy presents a novel therapeutic avenue.

Conclusions:

• A deeper understanding of sepsis pathophysiology and immune mechanisms is essential.
• Biomarker-guided immunotherapy, timed to the correct immune phase, shows potential for treating sepsis.
• This approach could represent a significant advance in infectious disease management.